USE OF NEW TECHNOLOGIES FOR THE MANAGEMENT OF GLYCEMIA IN PATIENTS WITH VARIOUS CARBOHYDRATE METABOLISM DISORDERS DURING PREGNANCY
It has been established that during pregnancy women may develop physiological resistance to the action of insulin, which in itself is a risk factor for carbohydrate metabolism disorders. Early diagnosis of hyperglycemia in women at risk for diabetes at the beginning of pregnancy and in women with diagnosed diabetes before pregnancy at the planning stage may prevent pregnancy and childbirth complications. Self-monitoring of blood glucose for such patients is an integral part of the guidelines on follow-up of such women. The achievement of normoglycemia throughout the gestation period makes it possible to forecast perinatal outcomes such as reduced rates of development of macrosomia, severe degrees of diabetic fetopathy, and an increased rates of natural births. The use of modern technologies for the management of glycemia during pregnancy, namely portable glucometers for daily monitoring of blood glucose, determines the choice of therapy for women with various carbohydrate metabolism disorders during pregnancy.